DPK-DTSM-02

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameDPK-DTSM-02
Drug Alias Nameresveratrol analog (Dominion)FAS-21DPK-DTSM-02
ClassificationSmall molecules
Mechanisms of ActionNuclear factor NF-kappa-B complex modulatorsAngiogenesis inhibitorsMetastasis inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDominion-Pharmakine Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDominion-Pharmakine Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A